Traci C. Green Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Adjunct Associate Professor (Research), The Warren Alpert Medical School

John Brown University

faculty

52 h-index 258 pubs 8,882 cited

Research Areas

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Dr. Traci Green is an epidemiologist whose research focuses on prescription opioid use, opioid safety, and structural interventions to reduce drug-related harm. Her work includes epidemiologic studies of illicit drug and nonmedical prescription drug use, sexual and drug-use risk behaviors, and health service utilization among vulnerable populations. As director of a team at the Brandeis Opioid Policy Research Collaborative, she evaluates the Massachusetts CDC Overdose Data to Action grant, using community-based participatory research methods and drug checking technologies to assess state policies related to opioids and overdose. Green also helps direct the COBRE on Opioids and Overdose at Rhode Island Hospital, training scientists in overdose research. Her recent work includes studies modeling naloxone need across different opioid epidemics, evaluating equity in community-based naloxone access, and surveying North American drug checking services. She holds an appointment at The Warren Alpert Medical School and John Brown University. Her research also encompasses substance abuse treatment and outcomes, prenatal substance exposure effects, and pain management.

Metrics

h-index: 52
Publications: 258
Citations: 8,882

Selected Publications

Preventing overdoses involving stimulants: the POINTS study protocol (2024) DOI
Views and experiences of involuntary civil commitment of people who use drugs in Massachusetts (Section 35) (2024) DOI
Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study (2024) DOI
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement (2024) DOI
LatinX harm reduction capital, medication for opioid use disorder, and nonfatal overdose: A structural equation model analysis among people who use drugs in Massachusetts (2024) DOI
“I go out of my way to give them an extra smile now:” A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials (2024) DOI
Relationships Between Stigma, Risk Tolerance, and Buprenorphine Dispensing Intentions Among Community-Based Pharmacists: Results From a National Sample (2024) DOI
Costing analysis of a point-of-care drug checking program in Rhode Island (2023) DOI
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy (2023) DOI
Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City (2023) DOI
A survey of North American drug checking services operating in 2022 (2023) DOI
Xylazine in the drug supply: A research agenda (2023) DOI
Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts (2023) DOI
The police paradox: A qualitative study of post-overdose outreach program implementation through public health-public safety partnerships in Massachusetts (2023) DOI
Trends and correlates of abscess history among people who inject drugs in Massachusetts: A mixed methods exploration of experiences amidst a rapidly evolving drug supply (2023) DOI